Literature DB >> 17025253

Influence of long-term stability conditions on microbicidal nucleoside prodrug (WHI-07)-loaded gel-microemulsion.

Osmond J D'Cruz1, Fatih M Uckun.   

Abstract

The objective of this study was to evaluate the long-term stability of the antiretroviral spermicide WHI-07 (5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl)-methoxyalaninyl phosphate) in a polymer-based microemulsion. The recovery and stability of WHI-07 in gel-microemulsion was examined by a validated high-performance liquid chromatography (HPLC) method. The stability was examined over a period of 24 weeks at 3 controlled temperatures (4 degrees C, 25 degrees C, and 40 degrees C). The recovery of the prodrug from 0.5% to 2.0% WHI-07-loaded gel-microemulsion was 99.8%. HPLC analysis revealed that a 2% WHI-07-loaded gel-microemulsion stored at room temperature and cold temperatures for 24 weeks retained >90% of the prodrug, whereas those stored at 40 degrees C maintained 90% of initial WHI-07 for at least 10 weeks. The observed stability of WHI-07 in gel-microemulsion is of great importance for its widespread utility in various climatological conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025253      PMCID: PMC2750515          DOI: 10.1208/pt070373

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  26 in total

1.  Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (compounds WHI-05 and WHI-07) in normal human female genital tract epithelial cells and sperm.

Authors:  O J D'Cruz; T K Venkatachalam; F M Uckun
Journal:  Biol Reprod       Date:  2001-01       Impact factor: 4.285

Review 2.  Microemulsions: an overview and pharmaceutical applications.

Authors:  S Tenjarla
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1999       Impact factor: 4.889

Review 3.  Microemulsion-based media as novel drug delivery systems.

Authors:  M J Lawrence; G D Rees
Journal:  Adv Drug Deliv Rev       Date:  2000-12-06       Impact factor: 15.470

Review 4.  Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.

Authors:  Osmond J D'Cruz; Fatih M Uckun
Journal:  J Antimicrob Chemother       Date:  2006-01-23       Impact factor: 5.790

5.  Short-Term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice.

Authors:  O J D'Cruz; F M Uckun
Journal:  Toxicol Sci       Date:  2001-04       Impact factor: 4.849

Review 6.  Prophylactic contraceptives for HIV/AIDS.

Authors:  F M Uckun; O J D'Cruz
Journal:  Hum Reprod Update       Date:  1999 Sep-Oct       Impact factor: 15.610

7.  Lack of adverse effects on fertility of female CD-1 mice exposed to repetitive intravaginal gel-microemulsion formulation of a dual-function anti-HIV agent: aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07).

Authors:  O J D'Cruz; F M Uckun
Journal:  J Appl Toxicol       Date:  2001 Jul-Aug       Impact factor: 3.446

8.  Evaluation of subchronic (13-week) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (compound whi-07) in B(6)C(3)F(1) mice.

Authors:  O J D'Cruz; B Waurzyniak; S H Yiv; F M Uckun
Journal:  J Appl Toxicol       Date:  2000 Jul-Aug       Impact factor: 3.446

Review 9.  Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles.

Authors:  O J D'Cruz; F M Uckun
Journal:  Contraception       Date:  2001-08       Impact factor: 3.375

10.  Two-year toxicity and carcinogenicity studies in B(6)C(3)F(1) mice with 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent.

Authors:  Osmond J D'Cruz; Douglas Erbeck; Barbara Waurzyniak; Fatih M Uckun
Journal:  Toxicology       Date:  2002-09-30       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.